Home > PE Ratio > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
PE (Price/Earnings) Ratio

The Current P/E Ratio of NATH BIOGENES (INDIA) is 8.57.

Share Price ₹180.2Nov 25,2024
Market Cap ₹342.3 Cr
Earnings-TTM₹40.0 CrTTM-Consolidated Results
Price/Earnings8.57xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of NATH BIOGENES (INDIA)

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of NATH BIOGENES (INDIA) is calculated as :

Current Market Cap [ ₹342.3 Cr] as on Nov 25,2024

(/) Earnings [ ₹40.0 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 8.57x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for NATH BIOGENES (INDIA) , the investors are currently willing to pay 8.57 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of NATH BIOGENES (INDIA) !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of NATH BIOGENES (INDIA) over the last five years.

Historical PE (Price/Earnings) ratio chart of NATH BIOGENES (INDIA)


PE Ratio Performance Analysis for NATH BIOGENES (INDIA)

- NATH BIOGENES (INDIA) 's latest p/e ratio is 8.57x.

- NATH BIOGENES (INDIA) 's p/e ratio for fiscal years ending Mar2024 to Mar2012 averaged 3.20x.

- NATH BIOGENES (INDIA) 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, NATH BIOGENES (INDIA) 's p/e ratio peaked in Mar2024 at 8.33x.

- NATH BIOGENES (INDIA) 's p/e ratio hit its five-year low in Mar2022 of 0x.


How does NATH BIOGENES (INDIA) 's P/E Ratio benchmark against top 10 peers in Agriculture Industry?

Peer Comparison (Agriculture Industry)Earnings-TTM (Cr)PE RatioMarket Cap
NATH BIOGENES (INDIA) 39.968.57342.3
BOMBAY BURMAH TRADING CORPORATION LTD1,899.679.2717,603.8
KAVERI SEED COMPANY LTD300.9514.384,328.3
VENKYS (INDIA) LTD108.5122.112,399.4
BOMBAY SUPER HYBRID SEEDS LTD23.2063.561,474.5
TIERRA AGROTECH LTD-9.93-41.09408.2
INDO US BIOTECH LTD11.7444.07517.2
MANGALAM SEEDS LTD12.9116.83217.2
SHREE OSWAL SEEDS AND CHEMICALS LTD-9.23-19.77182.5
HARRISONS MALAYALAM LTD-4.38-111.18487.0
MANGALAM GLOBAL ENTERPRISE LTD26.2613.89364.7

Agriculture Industry Benchmark (Top 10) PE Analysis vs NATH BIOGENES (INDIA) 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -111.18x
Max industry PE 63.56x
Median industry PE 13.89x
Average industry PE 1.88x



You may also like the below Video Courses